|
[Related PubMed/MEDLINE] Total Number of Papers: 49
|
|
|
[Display Entries]
|
|
[Entries Per Page]
|
per page
|
|
Page Control
|
|
Page: of
|
|
|
|
Abbreviation |
: SERPIN |
Long Form |
: serine protease inhibitor |
|
No. |
Year |
Title |
Co-occurring Abbreviation |
1 |
2022 |
Anticoagulant SERPINs: Endogenous Regulators of Hemostasis and Thrombosis. |
--- |
2 |
2022 |
In silico docking screen identifies airway host protease targets for human SERPINs. |
--- |
3 |
2022 |
Unfolding the cascade of SERPINA3: Inflammation to cancer. |
SERPINA3 |
4 |
2021 |
Deep mutational scanning of the plasminogen activator inhibitor-1 functional landscape. |
PAI-1 |
5 |
2021 |
Targeted SERPIN (TaSER): A dual-action antithrombotic agent that targets platelets for SERPIN delivery. |
GPIbalpha, TaSER, vWF |
6 |
2021 |
The Expression Profile of Protease Inhibitors in the Airway Epithelial Cells after Allergen (Der p 1) Stimulation. |
Der p |
7 |
2020 |
Hypothesis: Alpha-1-antitrypsin is a promising treatment option for COVID-19. |
AAT, NETs, NF-kappaB |
8 |
2020 |
Post-Translational Modifications of Circulating Alpha-1-Antitrypsin Protein. |
AAT |
9 |
2020 |
Sunitinib decreases the expression of KRT6A and SERPINB1 in 3D human epidermal models. |
ERK, HFSR, KRT, MAPK |
10 |
2019 |
A Virus-Derived Immune Modulating Serpin Accelerates Wound Closure with Improved Collagen Remodeling. |
uPAR |
11 |
2019 |
Recognition of Plasminogen Activator Inhibitor Type 1 as the Primary Regulator of Fibrinolysis. |
PAI-1, PAs, TAFI, tPA, VECs |
12 |
2018 |
Molecular biomarkers of Graves' ophthalmopathy. |
GD, GO |
13 |
2017 |
Increased kallistatin levels in patients with obesity and prediabetes compared to normal glucose tolerance. |
--- |
14 |
2016 |
A small deletion in SERPINC1 causes type I antithrombin deficiency by promoting endoplasmic reticulum stress. |
AT, ER, INEL |
15 |
2016 |
Progressive myoclonus epilepsy associated with neuroserpin inclusion bodies (neuroserpinosis). |
FENIB, tPA |
16 |
2015 |
A small molecule PAI-1 functional inhibitor attenuates neointimal hyperplasia and vascular smooth muscle cell survival by promoting PAI-1 cleavage. |
CL-PAI-1, FGF, LRP1, PAI-1, uPA and tPA, VSMC |
17 |
2015 |
Protease nexin 1 induces apoptosis of prostate tumor cells through inhibition of X-chromosome-linked inhibitor of apoptosis protein. |
PN-1, SHH |
18 |
2015 |
Species-Specific Serological Detection for Schistosomiasis by Serine Protease Inhibitor (SERPIN) in Multiplex Assay. |
MFI |
19 |
2014 |
Functional and dysfunctional conformers of human neuroserpin characterized by optical spectroscopies and Molecular Dynamics. |
FENIB, NS |
20 |
2014 |
Identification and characterisation of eight novel SERPINA1 Null mutations. |
AAT, AATD, DBS |
21 |
2014 |
PAI-1-regulated extracellular proteolysis governs senescence and survival in Klotho mice. |
PAI-1, SMS |
22 |
2014 |
Pseudomonas aeruginosa elastase disrupts the cortisol-binding activity of corticosteroid-binding globulin. |
CBG, RCL |
23 |
2014 |
Serine protease inhibitor (SERPIN) B1 suppresses cell migration and invasion in glioma cells. |
FAK, MMP-2 |
24 |
2013 |
Corticosteroid-binding globulin: structure-function implications from species differences. |
CBG, RCL, S-to-R |
25 |
2013 |
Influence of pathogenic bacteria species present in the postpartum bovine uterus on proteome profiles. |
dpp, ENO1, PGAM1, PGLYRP1, PMN, SDS |
26 |
2013 |
Novel Combinatorial Therapeutic Targeting of PAI-1 (SERPINE1) Gene Expression in Alzheimer's Disease. |
APP, PAI-1 |
27 |
2012 |
Hypoxia negatively regulates antimetastatic PEDF in melanoma cells by a hypoxia inducible factor-independent, autophagy dependent mechanism. |
HIF, PEDF, UTRs |
28 |
2012 |
PAI-1, progress in understanding the clinical problem and its aetiology. |
tPA, uPA |
29 |
2011 |
Rock bream (Oplegnathus fasciatus) serpin, protease nexin-1: transcriptional analysis and characterization of its antiprotease and anticoagulant activities. |
AA, LPS, PN-1, Rb |
30 |
2011 |
SERPINE2, an inhibitor of plasminogen activators, is highly expressed in the human endometrium during the secretory phase. |
PAs |
31 |
2011 |
The discovery of alpha1-antitrypsin and its role in health and disease. |
AAT, COPD |
32 |
2010 |
Spatiotemporal expression of the serine protease inhibitor, SERPINE2, in the mouse placenta and uterus during the estrous cycle, pregnancy, and lactation. |
LC, PA |
33 |
2010 |
The neuroprotective role of PEDF: implication for the therapy of neurological disorders. |
PEDF |
34 |
2009 |
Serine protease inhibitor (SERPIN) B1 promotes oral cancer cell motility and is over-expressed in invasive oral squamous cell carcinoma. |
OSCC |
35 |
2008 |
Transgenic overexpression of a stable Plasminogen Activator Inhibitor-1 variant. |
PAI-1 |
36 |
2006 |
SERPINB1 upregulation is associated with in vivo complex formation with neutrophil elastase and cathepsin G in a baboon model of bronchopulmonary dysplasia. |
BPD, CatG, HMM, HPLC, NE |
37 |
2004 |
PAI-1 expression is required for epithelial cell migration in two distinct phases of in vitro wound repair. |
MLC, PAI-1 |
38 |
2004 |
Plasminogen activator inhibitor type-1 gene expression and induced migration in TGF-beta1-stimulated smooth muscle cells is pp60(c-src)/MEK-dependent. |
c-src, EGFR, PAI-1, TGF-beta1 |
39 |
2003 |
[Screening and cloning of genes encoding Schistosoma japonicum antigens related to the serum antibodies in Mirotus fortis]. |
GAPDH |
40 |
2002 |
Differential mechanisms of plasminogen activator inhibitor-1 gene activation by transforming growth factor-beta and tumor necrosis factor-alpha in endothelial cells. |
BAECs, PAI-1, TGF-beta, TNF-alpha |
41 |
2000 |
Selective consumption of thyroxine-binding globulin during cardiac bypass surgery. |
CABG, TBG, TTR |
42 |
2000 |
SERPIN regulation of factor XIa. The novel observation that protease nexin 1 in the presence of heparin is a more potent inhibitor of factor XIa than C1 inhibitor. |
FXIa, LRP, PN-1 |
43 |
2000 |
Topological localization of plasminogen activator inhibitor type 2. |
ELISA, PAI-2, uPA |
44 |
1999 |
Mutational analysis in antithrombin deficiency. |
--- |
45 |
1998 |
Analysis of a structural determinant in thrombin-protease nexin 1 complexes that mediates clearance by the low density lipoprotein receptor-related protein. |
LRP, PN-1, Th-PN1 |
46 |
1998 |
Receptor-mediated activation of murine peritoneal macrophages by antithrombin III acts as a costimulatory signal for nitric oxide synthesis. |
ATIII, IFN-gamma, NO |
47 |
1997 |
Mutation analysis and loss of heterozygosity of PEDF in central nervous system primitive neuroectodermal tumors. |
CNS, LOH, PEDF, PNETs, SSCP |
48 |
1997 |
The efficient catabolism of thrombin-protease nexin 1 complexes is a synergistic mechanism that requires both the LDL receptor-related protein and cell surface heparins. |
LRP, PN-1, TH, uPA |
49 |
1996 |
Complex regulation of plasminogen activator inhibitor type-1 (PAI-1) gene expression by serum and substrate adhesion. |
NRK, PAI-1 |
|